Anlotinib overcomes multiple drug resistant of the colorectal cancer cells via inactivating PI3K/AKT pathway

Weilan Lan(Fujian University of Traditional Chinese Medicine), Jiumao Lin(Fujian University of Traditional Chinese Medicine)
bioRxiv (Cold Spring Harbor Laboratory)
October 28, 2019
Cited by 4


Related Papers